Govt Job: For Scientists at United States Pharmacopeia (USP)

Apply Online

United States Pharmacopeia (USP) is proud to be an equal opportunity / affirmative action employer. Employment selection and related decisions are made without regard to sex, gender identity, race, age, disability, religion, national origin, color, veteran status or any other protected class.

We are committed to working with and providing reasonable accommodation to individuals with disabilities.

Post : Scientist III / Senior Scientist I CDL

Job Description
• Search relevant literature for the USP/NF monograph modernization projects.

• Responsible for the modernization / development project (initiation, execution, reporting, & completion).

• Should have worked on chromatography (HPLC, GC), mass spectrometry (LC- MS/MS, GC- MS/MS) techniques.

• Should have experience of method development and validations (DS/DP/Excipients).

• Responsible for design, review, and execution of method development experiments and perform method validation in accordance with laid down procedure.

• Responsible for preparation of method validation protocols and reports.

• Plan individually the project requirements and their completion within the time lines by coordinating with the supervisor.

• Responsible for procurement of chemicals, reagents, glassware, columns, project related samples, and general requirement on regular basis.

• Responsible for preparing regular project updates and communicating with internal customers through verbal and email communication.

• Responsible for preparation and review of SOPs, protocols, reports and ELNs.

• Responsible for instrument maintenance and ensuring good lab practices.

• Ensure that the calibrations of the equipment are performed as per the schedule.

• Responsible for review of IQ/OQ/PQ documents of instruments.

• Coordinate with supervisor for internal audits, ISO17025 and ISO9001.

• Maintain GLP & safety procedures while working in Lab.

Candidate Profile
• Master’s degree in Chemistry or relevant field.

• Minimum of 8-10 years (Senior Scientist I) or 5-7 years (Scientist III) of experience in the field of analytical method development and validations.

• Master’s Degree in Chemistry (Analytical / Organic) or Pharmaceutical Sciences with 8-10 years (Senior Scientist I) or 5-7 years (Scientist III) years of experience or PhD with at least 3-4 years of experience in relevant field.

• A candidate with an experience of analyzing genotoxic impurities (such nitrosamines) using LC-MS-MS and GC-MS-MS will be preferred

• Knowledge and exposure of analytical QbD approach.

• Excellent written and verbal communications skills.

• Technical and analytical skills required including the ability to interpret technical information.

• Must have hands on experience on handling instruments like HPLC, UHPLC, LC-MS, GC, GC-MS, IC, ICP-OES/MS, FTIR, UV-Visible etc.

• Must have experience of working in GMP environment and have exposure of regulatory guidelines.

• Ability to handle multiple priorities in a fast-paced environment.

Additional Information
Location :  Hyderabad, India
Industry Type : Pharma
Functional Area :  CDL
End Date : 30th Januaray, 2022

Related Posts

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’